Cargando…

Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”

Detalles Bibliográficos
Autores principales: Fitzgerald, Bryna L., Islam, M. Nurul, Graham, Barbara, Mahapatra, Sebabrata, Webb, Kristofor, Boom, W. Henry, Malherbe, Stephanus T., Joloba, Moses L., Johnson, John L., Winter, Jill, Walzl, Gerhard, Belisle, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580363/
https://www.ncbi.nlm.nih.gov/pubmed/30864780
http://dx.doi.org/10.1021/acsinfecdis.9b00068
_version_ 1783428012596789248
author Fitzgerald, Bryna L.
Islam, M. Nurul
Graham, Barbara
Mahapatra, Sebabrata
Webb, Kristofor
Boom, W. Henry
Malherbe, Stephanus T.
Joloba, Moses L.
Johnson, John L.
Winter, Jill
Walzl, Gerhard
Belisle, John T.
author_facet Fitzgerald, Bryna L.
Islam, M. Nurul
Graham, Barbara
Mahapatra, Sebabrata
Webb, Kristofor
Boom, W. Henry
Malherbe, Stephanus T.
Joloba, Moses L.
Johnson, John L.
Winter, Jill
Walzl, Gerhard
Belisle, John T.
author_sort Fitzgerald, Bryna L.
collection PubMed
description
format Online
Article
Text
id pubmed-6580363
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-65803632019-06-20 Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy” Fitzgerald, Bryna L. Islam, M. Nurul Graham, Barbara Mahapatra, Sebabrata Webb, Kristofor Boom, W. Henry Malherbe, Stephanus T. Joloba, Moses L. Johnson, John L. Winter, Jill Walzl, Gerhard Belisle, John T. ACS Infect Dis American Chemical Society 2019-03-13 2019-06-14 /pmc/articles/PMC6580363/ /pubmed/30864780 http://dx.doi.org/10.1021/acsinfecdis.9b00068 Text en Copyright © 2019 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Fitzgerald, Bryna L.
Islam, M. Nurul
Graham, Barbara
Mahapatra, Sebabrata
Webb, Kristofor
Boom, W. Henry
Malherbe, Stephanus T.
Joloba, Moses L.
Johnson, John L.
Winter, Jill
Walzl, Gerhard
Belisle, John T.
Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
title Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
title_full Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
title_fullStr Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
title_full_unstemmed Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
title_short Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
title_sort correction to “elucidation of a novel human urine metabolite as a seryl-leucine glycopeptide and as a biomarker of effective anti-tuberculosis therapy”
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580363/
https://www.ncbi.nlm.nih.gov/pubmed/30864780
http://dx.doi.org/10.1021/acsinfecdis.9b00068
work_keys_str_mv AT fitzgeraldbrynal correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT islammnurul correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT grahambarbara correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT mahapatrasebabrata correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT webbkristofor correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT boomwhenry correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT malherbestephanust correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT jolobamosesl correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT johnsonjohnl correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT winterjill correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT walzlgerhard correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy
AT belislejohnt correctiontoelucidationofanovelhumanurinemetaboliteasaserylleucineglycopeptideandasabiomarkerofeffectiveantituberculosistherapy